Recently the American Association for the Study of Liver Disease (AASLD) guidance for Wilson Disease (WD) has been released. In addition, a number of European guidelines in WD have been developed to date. What are the commonalities and differences of these guidelines in the approach to diagnosis and management of WD? This live roundtable discussion will provide a recap of the recommendations and discuss their application to today’s practice. Join Medscape’s expert panel for this essential primer on the updated recommendations for the management of WD!
Enhance Your Virtual Experience With Backstage Pass!
Join our 30-minute post-symposium breakout session connecting the program speakers and audience in the virtual environment. Backstage Pass provides an intimate virtual session where you can interact with faculty, address case-based questions, and facilitate relationship building.
The goal of this activity is to enable learners to better understand guideline updates in the management of WD and to provide answers to questions from learners.
Upon completion of this activity, participants will: Have increased knowledge regarding the [LIST][ITEM]Latest recommendations for the management of WD[/LIST]Demonstrate greater confidence in their ability to [LIST][ITEM]Implement the latest recommendations for the management of WD in clinical practice[/LIST]
In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. [JALOGO][MEDSCAPE]
[bold]For Physicians[/bold] Medscape, LLC designates this live activity for a maximum of 0.5 [bold][italic]AMA PRA Category 1 Credits™[/bold][/italic]. Physicians should claim only the credit commensurate with the extent of their participation in the activity.